Skip to main content
. 2016 Mar 16;2016:9754808. doi: 10.1155/2016/9754808

Table 2.

Pharmacological therapy present in the study cohort.

Pharmacological profile (n = 17)
Antithrombotic therapy
 Aspirin, n (%) 4 (23.5)
 Warfarin, n (%) 13 (76.5)
Rate and/or rhythm control therapy
 Antiarrhythmics, n (%) 5 (29.4)
β receptor antagonist, n (%) 11 (64.7)
RAAS inhibitors
 ACE inhibitor, n (%) 9 (52.9)
 Angiotensin receptor antagonist, n (%) 5 (29.4)
Other medications
 Statin, n (%) 6 (35.3)